Retatrutide 12mg Injection (Lyophilized)

Retatrutide 12mg is a research-grade lyophilized peptide supplied in sterile vial format for pharmaceutical research and development applications. Retatrutide is a synthetic peptide compound studied within advanced metabolic and multi-receptor research programs. This product is offered strictly for international export to licensed research institutions and pharmaceutical R&D organizations and is not intended for clinical treatment, retail distribution, or consumer use.

Active Ingredient

• Retatrutide – 12 mg per vial
  Retatrutide is a laboratory-synthesized peptide evaluated in controlled research environments for its interaction with multiple metabolic receptor pathways.

Therapeutic Use
This product is supplied for pharmaceutical research and R&D use only. Retatrutide 12 mg is intended exclusively for non-clinical laboratory research, analytical studies, and developmental programs conducted by authorized institutions. AmeriDrugs does not provide medical advice, therapeutic claims, or guidance for human use.

Dosage Form

• Lyophilized (freeze-dried) powder

• Supplied in sterile, sealed pharmaceutical-grade glass vials

• Handling, reconstitution, and application are restricted to qualified research professionals operating under approved laboratory protocols

Quality & Manufacturing Standards
Retatrutide 12 mg is manufactured in a controlled environment under strict quality management systems aligned with international export standards. Each batch undergoes validated analytical testing to confirm identity, purity, and consistency.

• Purity confirmed at ≥99% by HPLC

• Research-grade material suitable for regulated R&D applications

• Controlled manufacturing and quality assurance processes

Packaging Information

• Sterile amber glass vial

• Aluminum flip-off seal with rubber stopper

• Secure secondary packaging designed for international shipping and export logistics

• Packaging supports product stability during long-term research storage

Target Buyers
This product is intended exclusively for supply to:

• Pharmaceutical research and development companies

• Biotechnology and life science firms

• Academic and institutional research laboratories

• Contract research organizations (CROs)

• Licensed importers of research-grade pharmaceutical materials

It is not intended for retail sale, prescription dispensing, or direct human consumption.

Regulatory & Compliance Note
Retatrutide 12 mg is supplied strictly as a Research Use Only (RUO) product.
For pharmaceutical manufacturing research and R&D use only.
Not for retail sale, clinical use, or direct human consumption.

Importation, storage, handling, and use must comply with the regulatory, customs, and research material requirements of the destination country. AmeriDrugs operates solely as an export-focused pharmaceutical and research material supplier and does not promote this product for therapeutic, diagnostic, or patient-facing applications.